KDR and myocardial infarction: - In vitro: The modification didn’t affect the metabolic activity or induce cytotoxicity of HUVECs. Adhesion of HUVECs was increased on VEGFR2 scFv surfaces.- In vivo: stents were implanted into porcine arteries for 5 and 30-days. There was no evidence of restenosis, thrombosis, or myocardial infarction at both time points. Stent coverage was significantly higher in modified stents when compared to BMS at 5 days. No significant difference was detected at 30 days. Histological sections showed coverage with a cell layer (80 μm) by day 30.